Table 3.
Studies analyzed for each type of impulsivity
|
Sensation Seeking | |||
|---|---|---|---|
| Study | N | Design | Weighted ES |
| Abbate- Daga, et al., 2005 | 260 | Group comparison | .34 |
| Baker, 1998 | 196 | Continuous symptom measure | .04 |
| Berg, et al., 2000 | 57 | Group comparison | .08 |
| Brookings & Wilson, 1994 | 137 | Continuous symptom measure | .12 |
| Claes, et al., 2005 | 143 | Continuous symptom measure | .10 |
| Claes, et al., 2006 | 105 | Group comparison | .04 |
| Claes, et al., 2002 | 133 | Group comparison | −.13 |
| Fassino, et al., 2001 | 95 | Group comparison | .21 |
| Fassino, et al., 2002 | 202 | Group comparison | .19 |
| Fassino, et al., 2003 | 57 | Group comparison | .30 |
| Fischer & Smith, 2008 | 246 | Continuous symptom measure | −.04 |
| Fischer, et al., 2007 | 66 | Group comparison | .13 |
| Gendall, et al., 1998 | 223 | Group comparison | .08 |
| Nagata, et al., 2003 | 176 | Group comparison | −.11 |
| Newton, et al., 1993 | 85 | Group comparison | .03 |
| Rossier, et al., 2000 | 112 | Group comparison | .29 |
| Rosval, et al., 2006 | 138 | Group comparison | .34 |
| Schumaker, et al, 1986 | 65 | Group comparison | −.01 |
| Steiger, et al., 1991 | 667 | Group comparison | .34 |
| Vervaet, et al, 2003 | 318 | Continuous symptom measure | .27 |
|
Urgency | |||
| Study | N | Design | Weighted ES |
|---|---|---|---|
| Brookings & Wilson, 1994 | 137 | Continuous symptom measure | .50 |
| Bruce, et al., 2002 | 67 | Group comparison | .42 |
| Claes, et al., 2006 | 106 | Group comparison | .25 |
| Claes, et al., 2005 | 146 | Continuous symptom measure | .50 |
| Fischer, et al., 2007 | 66 | Group comparison | .44 |
| Fischer & Smith, 2008 | 246 | Continuous symptom measure | .22 |
| Fischer, et al., 2004 | 217 | Continuous symptom measure | .25 |
| Fischer, et al., 2003 | 291 | Continuous symptom measure | .30 |
| Fischer, et al., 2003 | 101 | Continuous symptom measure | .49 |
| Heaven, et al., 2001 | 167 | Continuous symptom measure | .56 |
| Lyke & Spinella, 2004 | 112 | Continuous symptom measure | .42 |
| Newton, et al., 1993 | 85 | Group comparison | .14 |
| Rosval, et al., 2006 | 138 | Group comparison | .58 |
| Steiger, et al., 2001 | 48 | Group comparison | .30 |
| Steiger, et al., 2000 | 51 | Group comparison | .66 |
|
Lack of Persistence | |||
| Study | N | Design | Weighted ES |
|---|---|---|---|
| Abbate Daga, et al., 2005 | 260 | Group comparison | .11 |
| Claes, et al., 2005 | 143 | Continuous symptom measure | .39 |
| Fassino, et al., 2002 | 202 | Group comparison | −.02 |
| Fassino, et al., 2001 | 95 | Group comparison | .10 |
| Fischer & Smith, 2008 | 246 | Continuous symptom measure | .11 |
| Fischer, et al., 2007 | 66 | Group comparison | .22 |
| Gendall, et al., 1998 | 162 | Group comparison | .11 |
| Heaven, et al., 2001 | 167 | Continuous symptom measure | .17 |
| Nagata, et al., 2003 | 176 | Group comparison | −.26 |
| Rossier, et al., 2000 | 112 | Group comparison | .09 |
| Schumaker, et al., 1986 | 65 | Group comparison | −.14 |
| Tylka & Subich, 1999 | 169 | Group comparison | .13 |
| Vervaet, et al,, 2003 | 318 | Continuous symptom measure | .09 |
|
Lack of Planning/Deliberation | |||
| Study | N | Method | Weighted Effect Size |
|---|---|---|---|
| Baker, 1998 | 196 | Continuous symptom measure | .25 |
| Benjamin & Wulfert, 2005 | 335 | Continuous symptom measure | .13 |
| Bruce, et al., 2002 | 69 | Group Comparison | .34 |
| Casper, et al., 1992 | 28 | Group Comparison | .14 |
| Claes, et al., 2005 | 146 | Continuous symptom measure | .39 |
| Claes, et al., 2006 | 105 | Group Comparison | .07 |
| Claes, et al., 2006 | 105 | Group Comparison | .06 |
| Claes, et al., 2002 | 133 | Group Comparison | .17 |
| Culbert & Klump, 2005 | 500 | Continuous symptom measure | .18 |
| Diaz-Marsa, et al., 2000 | 102 | Continuous symptom measure | .23 |
| Fassino, et al., 2002 | 202 | Group Comparison | .19 |
| Fischer, et al., 2003 | 291 | Continuous symptom measure | .06 |
| Fischer, et al., 2003 | 101 | Continuous symptom measure | .19 |
| Fischer & Smith, 2008 | 246 | Continuous symptom measure | .06 |
| Fischer, et al., 2007 | 66 | Group comparison | .10 |
| Fossati, et al., 2001 | 663 | Group comparison | .18 |
| Franko & Omori, 1999 | 124 | Group comparison | 0 |
| Harnden —Fischer, 2000 | 352 | Group comparison | .20 |
| Heaven, et al., 2001 | 167 | Continuous symptom measure | .21 |
| Kane, et al., 2004 | 43 | Group comparison | .54 |
| Kent, et al., 1997 | 48 | Continuous symptom measure | .50 |
| Klump, et al., 2002 | 512 | Continuous symptom measure | .07 |
| Lehoux & Howe, 2007 | 78 | Group comparison | .37 |
| Leon, et al., 1999 | 736 | Continuous symptom measure | .05 |
| Loxton & Dawe, 2007 | 131 | Continuous symptom measure | .19 |
| Lyke & Spinella, 2004 | 112 | Continuous symptom measure | .17 |
| Newton, et al., 1993 | 85 | Group comparison | .19 |
| Shaye, et al., 1986 | 64 | Group comparison | .12 |
| Steiger, et al., 1999 | 51 | Continuous symptom measure | .26 |
| Steiger, et al., 2000 | 51 | Group Comparison | .32 |
| Steiger, et al., 2001 | 48 | Group Comparison | .21 |
| Steiger, et al., 2003 | 85 | Group Comparison | .44 |
| Steiger et al., 2004 | 121 | Group comparison | .45 |
| Stice, et al., 2001 | 231 | Continuous symptom measure | .08 |
| Stice & Agras, 1998 | 218 | Continuous symptoms measure | .06 |
| Stein, et al., 2002 | 26 | Group comparison | 0 |
| Rosval, et al., 2006 | 138 | Group comparison | .21 |
| Wolfe, et al., 1994 | 40 | Group Comparison | .62 |